Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangements

Lignende værker

• Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
  af: Subbiah, V., et al.
  Udgivet: (2021)
• Atypical Carcinoid Tumor with Anaplastic Lymphoma Kinase (ALK) Rearrangement Successfully Treated by an ALK Inhibitor
  af: Nakajima, Masayuki, et al.
  Udgivet: (2016)
• Current and future treatment of anaplastic lymphoma kinase-rearranged cancer
  af: Mologni, Luca
  Udgivet: (2015)
• Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
  af: Iwama, Eiji, et al.
  Udgivet: (2014)
• The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
  af: Golding, Brandon, et al.
  Udgivet: (2018)